Drug Approval | May 19, 2026
FDA expands Enhertu use in early HER2-positive breast cancer
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
Access to genomic testing, not therapy cost, is the biggest challenge
New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
Subscribe To Our Newsletter & Stay Updated
